Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

Overview of attention for article published in Blood, February 2001

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 1 X user

patent: 133 patents

Readers on

mendeley: 96 Mendeley

So far, Altmetric has seen 133 patents that reference this research output.

Tricyclic heterocycles as FGFR inhibitors

Grant US-12552804-B2

United States of America

17 Feb 2026

Solid forms of an FGFR inhibitor and processes for preparing the same

Grant US-12552792-B2

United States of America

17 Feb 2026

Substituted tricyclic compounds as FGFR inhibitors

Grant US-12534463-B2

United States of America

27 Jan 2026

Quinoline derivative-containing pharmaceutical composition

Grant US-12508313-B2

United States of America

30 Dec 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 129 additional patents.